Skip to main content

Thomas Anthony D'Amico, MD

Gary Hock Distinguished Professor of Surgery
Director, Integrated Thoracic Surgery Residency Program and Joint General Surgery and Thoracic Surgery Residency Program
Director, Advanced Training in Cardiothoracic Surgery
Professor of Surgery
Office: Duke South - 3589 White Zone, Durham, NC 27710
Campus Mail: DUMC Box 3496 Med Ctr, Durham, NC 27710

Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations

Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Education and Training

  • M.D., Columbia University, 1987

Publications

Ranney, David N., Michael S. Mulvihill, Babatunde A. Yerokun, Zachary Fitch, Zhifei Sun, Chi-Fu Yang, Thomas A. D’Amico, and Matthew G. Hartwig. “Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?” Eur J Cardiothorac Surg 52, no. 3 (September 1, 2017): 543–51. https://doi.org/10.1093/ejcts/ezx132.

Full Text

Yerokun, Babatunde A., Chi-Fu Jeffrey Yang, Brian C. Gulack, Xuechan Li, Michael S. Mulvihill, Lin Gu, Xiaofei Wang, et al. “A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.” J Thorac Cardiovasc Surg 154, no. 2 (August 2017): 675-686.e4. https://doi.org/10.1016/j.jtcvs.2017.02.065.

Full Text

Anderson, Kevin L., Michael S. Mulvihill, Babatunde A. Yerokun, Paul J. Speicher, Thomas A. D’Amico, Betty C. Tong, Mark F. Berry, and Matthew G. Hartwig. “Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.” Eur J Cardiothorac Surg 52, no. 2 (August 1, 2017): 370–77. https://doi.org/10.1093/ejcts/ezx091.

Full Text

Tandberg, Daniel J., Chris R. Kelsey, Thomas A. D’Amico, Jeffrey Crawford, Junzo P. Chino, Betty C. Tong, Neal E. Ready, and Ato Wright. “Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.” Clin Lung Cancer 18, no. 4 (July 2017): e259–65. https://doi.org/10.1016/j.cllc.2016.11.008.

Full Text

Yang, Chi-Fu Jeffrey, Derek Y. Chan, Paul J. Speicher, Brian C. Gulack, Betty C. Tong, Matthew G. Hartwig, Christopher R. Kelsey, Thomas A. D’Amico, Mark F. Berry, and David H. Harpole. “Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.” Ann Thorac Surg 103, no. 6 (June 2017): 1767–72. https://doi.org/10.1016/j.athoracsur.2017.01.043.

Full Text

Liang, Wenhua, Jiaxi He, Yaxing Shen, Jianfei Shen, Qihua He, Jianrong Zhang, Gening Jiang, et al. “Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.” J Clin Oncol 35, no. 11 (April 10, 2017): 1162–70. https://doi.org/10.1200/JCO.2016.67.5140.

Full Text

Ettinger, David S., Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica Bauman, Lucian R. Chirieac, Thomas A. D’Amico, et al. “Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 15, no. 4 (April 2017): 504–35. https://doi.org/10.6004/jnccn.2017.0050.

Full Text

Cox, Morgan L., Chi-Fu Jeffrey Yang, Paul J. Speicher, Kevin L. Anderson, Zachary W. Fitch, Lin Gu, Robert Patrick Davis, et al. “The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.” J Thorac Oncol 12, no. 4 (April 2017): 689–96. https://doi.org/10.1016/j.jtho.2017.01.003.

Full Text

Pages